17 completed, 3 unknown, 2 terminated. 22 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 22 | Completed 17, Unknown 3, Terminated 2 |
Follow Coronary Arteriosclerosis: new trials by email Literature Review of Coronary Arteriosclerosis trials Research Report on Coronary Arteriosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment Allicor, Placebo - Myocardial Ischemia, Coronary Artery Bypass Grafting | Phase 4 | Unknown | Institute for Atherosclerosis Research, Russia | 200 | 2023-04-10 | 2023-04-19 |
| EARly Prevention of aTHeroma Progression Standard Therapy, Rosuvastatin - Coronary Arteriosclerosis | Phase 4 | Terminated | CHEOL WHAN LEE, M.D., Ph.D | 111 | 2014-06-01 | 2018-06-25 |
| Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Ivabradine, Placebo - Coronary Artery Disease, Coronary Arteriosclerosis | Phase 4 | Unknown | University Hospital, Saarland | 50 | 2012-12-01 | 2013-01-15 |
| The Elderly ACS II Trial prasugrel, Clopidogrel - Acute Coronary Syndrome, Coronary Arteriosclerosis | Phase 4 | Completed | Azienda USL Reggio Emilia - IRCCS | 1457 | 2012-11-01 | 2025-06-24 |
| Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation. Aspirin - Coronary Arteriosclerosis | Phase 4 | Completed | University of Roma La Sapienza | 100 | 2011-01-01 | 2013-05-14 |
| XIENCE V: SPIRIT WOMEN Sub-study XIENCE V®/ XIENCE PRIME™, CYPHER SELECT - Coronary Artery Stenosis, Coronary Arteriosclerosis | Phase 4 | Completed | Abbott Medical Devices | 455 | 2008-09-01 | 2012-08-07 |
| XIENCE V: SPIRIT WOMEN XIENCE V®/ XIENCE PRIME™ - Coronary Artery Stenosis, Coronary Arteriosclerosis | Phase 4 | Completed | Abbott Medical Devices | 1600 | 2007-07-01 | 2015-05-13 |
| Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease Paracetamol - Coronary Arteriosclerosis, Endothelial Function | Phase 4 | Completed | University of Zurich | 37 | 2006-11-01 | 2019-12-03 |
| YUKON Choice Versus TAXUS Liberté in Diabetes Mellitus Yukon Choice stent system, Taxus Liberté stent system - Coronary Arteriosclerosis | Phase 4 | Completed | University of Leipzig | 240 | 2006-09-01 | 2010-02-02 |
| Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS) Multidetector Computed Tomography Coronary Angiography - Coronary Arteriosclerosis, Cardiomyopathies | Phase 4 | Completed | St. Joseph's Healthcare Hamilton | 168 | 2006-09-01 | 2010-11-25 |
| Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST) Iodixanol 320, Iomeprol 350 - Renal Insufficiency, Chronic, Angioplasty, Transluminal, Percutaneous Coronary | Phase 4 | Completed | Deutsches Herzzentrum Muenchen | 324 | 2006-07-01 | 2010-03-15 |
| Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment Integration of a team based clinical pharmacist, Optimizing therapeutic treatments, Optimizing processes of care - Heart Failure, Congestive, Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | University of Alberta | 452 | 2006-02-01 | 2007-12-11 |
| The Low HDL On Six Weeks Statin Therapy (LOW) Study Nicotinic acid - HDL Cholesterol, Coronary Arteriosclerosis | Phase 4 | Unknown | Craigavon Area Hospital | 60 | 2005-11-01 | 2006-09-13 |
| Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED) Ezetimibe, Placebo, Atorvastatin 10 mg - Hypercholesterolemia, Coronary Arteriosclerosis | Phase 4 | Completed | Organon and Co | 22 | 2005-09-01 | 2022-02-09 |
| Effects of Celecoxib After Percutaneous Coronary Intervention Celecoxib - Coronary Arteriosclerosis | Phase 4 | Completed | Seoul National University Hospital | 260 | 2004-08-01 | 2011-07-21 |
| Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients modified-release dipyridamole/aspirin, aspirin - Coronary Arteriosclerosis | Phase 4 | Completed | Boehringer Ingelheim | 11 | 2004-04-01 | 2025-01-23 |
| Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) Atorvastatin (Lipitor) - Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2080 | 2003-01-01 | 2021-02-18 |
| Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets Atorvastatin (Lipitor) - Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 595 | 2003-01-01 | 2021-02-18 |
| Comparative Atorvastatin Pleiotropic Effects Blood samples, Atorvastatin - Coronary Arteriosclerosis, Hypercholesterolemia | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 330 | 2002-06-01 | 2021-02-18 |
| Inflammation and Coronary Artery Disease: Role of AT1-Receptor Antagonism telmisartan 40 mg, placebo 40 mg - Hypertension, Coronary Arteriosclerosis | Phase 4 | Completed | Boehringer Ingelheim | 42 | 2001-12-01 | 2013-11-01 |
Showing 20 of 22. Sign in to see all of them.
Coronary Artery Disease (22) · Myocardial Ischemia (4) · Diabetes Mellitus, Type 2 (3) · Coronary Restenosis (2) · Coronary Stenosis (2) · Dyslipidemias (2) · Hypercholesterolemia (2) · Hypertension (2) · Peripheral Vascular Diseases (2) · Stroke (2) · Vascular Diseases (2) · Acute Coronary Syndrome (1) · Cardiomyopathies (1) · Cardiovascular Diseases (1) · Heart Defects, Congenital (1)
Arterial Occlusive Diseases (22) · Arteriosclerosis (22) · Coronary Disease (22) · Heart Diseases (22) · Cardiovascular Diseases (21) · Vascular Diseases (20) · Myocardial Ischemia (18) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Lipid Metabolism Disorders (4) · Diabetes Mellitus (3) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Atorvastatin (5) · Aspirin (2) · Telmisartan (2) · Acetaminophen (1) · Blood Specimen Collection (1) · Celecoxib (1) · Clopidogrel (1) · Ezetimibe (1) · Ivabradine (1) · Niacin (1) · Prasugrel Hydrochloride (1) · Pravastatin (1) · Rosuvastatin Calcium (1) · Standard of Care (1) · iodixanol (1)
Boehringer Ingelheim (3) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3) · Abbott Medical Devices (2) · Azienda USL Reggio Emilia - IRCCS (1) · CHEOL WHAN LEE, M.D., Ph.D (1) · Craigavon Area Hospital (1) · Deutsches Herzzentrum Muenchen (1) · Institute for Atherosclerosis Research, Russia (1) · Organon and Co (1) · Pfizer (1) · Seoul National University Hospital (1) · St. Joseph's Healthcare Hamilton (1) · University Hospital, Saarland (1) · University of Alberta (1) · University of Leipzig (1)
Germany (7) · Italy (5) · Canada (4) · Poland (4) · Russia (4) · Switzerland (4) · France (3) · Hungary (3) · Spain (3) · United Kingdom (3) · Argentina (2) · Austria (2) · Belgium (2) · Brazil (2) · Denmark (2)
Marie-Claude Morice (2) · Stephan Windecker (2) · Alan Moody, MD (1) · Albert Schoemig, MD (1) · Benjamin Chow, MD (1) · Bon-Kwon Koo, MD, PhD (1) · Frank Ruschitzka, MD (1) · Gaetano Tanzilli, Prof. (1) · Holger Thiele, MD (1) · I Menown, MD FRCP (1) · Marcello Dominici, MD (1) · Michael Freeman, MD (1)
PMID 17626713, PMID 17707751, PMID 19167589, PMID 19217176, PMID 19234987, PMID 19433997, PMID 20031753, PMID 20484099, PMID 20956208, PMID 21403014, PMID 21511226, PMID 21610204, PMID 23873579, PMID 25074252, PMID 25940520, PMID 27823681, PMID 28796809, PMID 29459361, PMID 30636561
2004 (1)